CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) |
1 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Changes in Assets and Liabilities, net of Acquisitions: | ||||||
| Net Cash used in Operating Activities | $ (1,586,548) | |||||
| Cash Flows From Investing Activities | ||||||
| Net Cash used in Investing Activities | (316,250,000) | |||||
| Cash Flows From Financing Activities | ||||||
| Net Cash used in (provided by) Financing Activities | 317,757,971 | |||||
| Cash and Restricted Cash, Beginning of Period | $ 100,935 | $ 179,512 | 179,512 | |||
| Cash and Restricted Cash, End of Period | $ 100,935 | $ 179,512 | ||||
| P3 Health Partners Inc. | ||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Predecessor | Predecessor | Predecessor | Predecessor |
| Net loss attributable to Class A common stockholders - Diluted | $ (57,937,929) | $ (963,896,193) | $ (54,115,119) | $ (146,399,938) | $ (31,411,542) | $ (41,971,558) |
| Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities: | ||||||
| Depreciation Expense | 187,558 | 1,540,335 | 795,172 | 399,177 | ||
| Amortization of Intangible Assets | 6,961,666 | 42,285,014 | 34,396 | |||
| Stock-Based Compensation | 4,635,142 | 15,426,980 | 1,024,307 | 3,701,252 | 447,475 | 474,042 |
| Amortization of Debt Origination Fees | 349,324 | 658,587 | 80,237 | |||
| Amortization of Discount from Issuance of Debt | 621,305 | 1,139,060 | 144,971 | |||
| Mark-to-Market Adjustment of Stock Warrants | (2,271,659) | (5,953,817) | 10,661,579 | 7,664,869 | ||
| Premium Deficiency Reserve | 26,276,575 | (2,814,084) | 3,000,000 | 11,559,067 | (20,539,364) | 6,363,652 |
| Changes in Assets and Liabilities, net of Acquisitions: | ||||||
| Accounts Receivable | 1,467,289 | (376,219) | 92,491 | (1,484,932) | 139,212 | 424,137 |
| Health Plan Receivables / Premiums | 3,236,036 | (49,555,406) | 1,212,093 | (2,770,246) | (27,507,240) | (9,653,991) |
| Other Current Assets | (4,704,294) | 1,890,414 | (361,241) | 4,254,368 | (4,160,078) | (122,765) |
| Net Change in ROU Assets and Liabilities | (21,886) | 305,677 | (704,500) | (1,620,600) | ||
| Accounts Payable | 7,731,972 | 1,163,574 | (1,005,876) | 34,224,416 | 8,102,668 | 803,503 |
| Accrued Payroll | 3,158,624 | (3,041,024) | (2,648,873) | (1,134,709) | 2,289,655 | 502,602 |
| Accrued Interest | (497,781) | 2,558,865 | 1,807,007 | 5,216,440 | 1,848,265 | 2,204,141 |
| Health Plan Payables / Premiums | (2,591,997) | (4,526,299) | (1,342,803) | 11,264,767 | 8,804,203 | 1,853,358 |
| Claims Payable | (971,210) | 37,364,043 | 5,736,206 | 19,097,060 | 37,075,052 | 12,057,792 |
| Net Cash used in Operating Activities | (15,341,894) | (73,087,629) | (34,131,885) | (51,129,531) | (24,595,814) | (28,286,510) |
| Cash Flows From Investing Activities | ||||||
| Purchases of Property, Plant and Equipment | (120,559) | (1,400,511) | (1,883,226) | (3,290,482) | (2,926,621) | (1,451,861) |
| Acquisitions, Net of Cash Acquired | (47,879,102) | (82,000) | (4,989,000) | (130,000) | ||
| Notes Receivable, Net | 143,297 | 226,808 | 70,650 | (109,527) | (2,404,862) | |
| Net Cash used in Investing Activities | (47,856,364) | (1,400,511) | (1,738,418) | (8,208,832) | (3,166,148) | (3,856,723) |
| Cash Flows From Financing Activities | ||||||
| Issuance (Redemption) of Class A, C and D Units | (180,000) | 62,041,554 | ||||
| Proceeds from PIPE, Net of Issuance Costs | 195,307,872 | |||||
| Proceeds from Long-Term Debt, Net of Discount and Issuance Costs | 12,750,000 | 24,625,000 | 36,433,282 | 16,164,914 | ||
| Proceeds from Short-Term Debt | 3,377,329 | 351,872 | ||||
| Repayment of Long-Term Debt | (8,008) | (2,446,433) | (44,629) | (186,519) | (1,493,221) | (14,586,891) |
| Net Cash used in (provided by) Financing Activities | 198,677,193 | (2,446,433) | 12,514,121 | 24,790,353 | 34,760,061 | 63,619,577 |
| Net Change in Cash and Restricted Cash | 135,478,935 | (76,934,573) | (23,356,182) | (34,548,010) | 6,998,099 | 31,476,344 |
| Cash and Restricted Cash, Beginning of Period | 5,354,937 | 140,833,872 | 39,902,947 | 39,902,947 | 32,904,848 | 1,428,504 |
| Cash and Restricted Cash, End of Period | 140,833,872 | $ 63,899,299 | $ 16,546,765 | 5,354,937 | 39,902,947 | 32,904,848 |
| Supplemental Cash Flow Information: | ||||||
| Cash Paid for Interest | $ 1,346,254 | $ 2,796,368 | 685,419 | 560,246 | ||
| Accrued Costs for Software (Development in Process) | $ 249,454 | 176,352 | ||||
| Conversion of Class A Units to Long-Term Debt | 15,000,000 | |||||
| Conversion of Long-Term Debt to Class A Units | $ 3,764,245 | |||||
| X | ||||||||||
- Definition The increase (decrease) during the reporting period for claims payables. No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period for health plan payables / premiums. No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period for health plan receivables / premiums. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment mark-to-market adjustment of stock warrants. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of net change in right of use assets and liabilities. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of medical expenses incurred during the period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of amortization expense attributable to debt issuance costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Future cash outflow to pay for purchases of fixed assets that have occurred. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the acquisition of a business when the cash held by the acquired business exceeds the cash payments to acquire the business. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period in other expenses incurred but not yet paid. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in current assets classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash inflows (outflows) from issuing and redeeming redeemable preferred stock; includes convertible and nonconvertible redeemable preferred stock. No definition available.
|
| X | ||||||||||
- Definition The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|